CORRECTING and REPLACING Catasys to Present at the Canaccord Genuity 38th Annual Growth Conference

Headline of release dated August 1, 2018, should read: Catasys to Present at the Canaccord Genuity 38th Annual Growth Conference (instead of Catasys to Present at the Cannacord Genuity 38thAnnual Growth Conference). Also, the first paragraph, first sentence should read: Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, and Mr. Christopher Shirley, the Company’s Chief Financial Officer, are scheduled to present at the Canaccord Genuity 38th Annual Growth Conference on Wednesday, August 8, 2018, at 10:30 a.m. ET (instead of ...to present at the Cannacord Genuity 38th Annual Growth Conference).

The corrected release reads:

CATASYS TO PRESENT AT THE CANACCORD GENUITY 38th ANNUAL GROWTH CONFERENCE

Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, and Mr. Christopher Shirley, the Company’s Chief Financial Officer, are scheduled to present at the Canaccord Genuity 38th Annual Growth Conference on Wednesday, August 8, 2018, at 10:30 a.m. ET. Management will also be participating in one-on-one meetings at the event that day.

The conference is scheduled to take place August 8-9, 2018, at the InterContinental Boston. The Company’s presentation will be made available via live webcast and in archive for up to 90 days following the conclusion of the event at http://wsw.com/webcast/canaccord30/cats/.

About Catasys, Inc.

Catasys, Inc. harnesses proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives.

Catasys' OnTrak solution--contracted with a growing number of national and regional health plans--is designed to treat members with behavioral conditions that cause or exacerbate co-existing medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.

Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance matched with data driven engagement technologies.

OnTrak integrates evidence-based medical and psychosocial interventions along with care coaching in a 52-week outpatient solution. The program is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency room utilization, driving a more than 50 percent reduction in total health insurers' costs for enrolled members. OnTrak is available to members of several leading health plans in California, Connecticut, Florida, Georgia, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, West Virginia and Wisconsin.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180801005201/en/